» Articles » PMID: 35366873

Retro-protein XXA is a Remarkable Solubilizing Fusion Tag for Inclusion Bodies

Overview
Publisher Biomed Central
Date 2022 Apr 3
PMID 35366873
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Producing large amounts of soluble proteins from bacteria remains a challenge, despite the help of current various solubilizing fusion tags. Thus, developing novel tags is necessary. Antifreeze protein (AFP) has excellent solubility and hydrophilicity, but there are no current reports on its use as a solubilizing fusion tag. Additionally, there is no precedent for using retro-proteins (reverse sequence) as solubilizing fusion tags. Therefore, we selected the antifreeze protein AXX and obtained its retro-protein XXA by synthesizing the XXA gene for the development of a new solubilizing fusion tag.

Results: XXA exhibits better stability and ease of expression than AXX; hence, we focused the development of the solubilizing fusion tag on XXA. XXA fused with the tested inclusion bodies, significantly increasing the soluble expression compared with commonly used solubilizing fusion tags such as GST, Trx, Sumo, MBP, and NusA. The tested proteins became soluble after fusion with the XXA tag, and they could be purified. They maintained a soluble form after XXA tag removal. Finally, we used enzymatic digestion reaction and western blot experiments to verify that bdNEDP1 and NbALFA, which were soluble expressed by fusion with XXA, were active.

Conclusion: We developed the novel solubilizing fusion tag XXA, which could more effectively facilitate the soluble expression of inclusion bodies compared with current commonly used tags. XXA could function at both low and high temperatures, and its moderate molecular weight has a limited impact on the output. These properties make XXA an ideal fusion tag for future research and industrial production. Moreover, for the first time, we highlighted the broad potential of antifreeze protein as a solubilizing fusion tag, bringing retro-protein into practical application.

Citing Articles

Improving Soluble Expression of SARS-CoV-2 Spike Priming Protease TMPRSS2 with an Artificial Fusing Protein.

Ye X, Ling X, Wu M, Bai G, Yuan M, Rao L Int J Mol Sci. 2023; 24(13).

PMID: 37445653 PMC: 10341623. DOI: 10.3390/ijms241310475.


Progress, applications, challenges and prospects of protein purification technology.

Du M, Hou Z, Liu L, Xuan Y, Chen X, Fan L Front Bioeng Biotechnol. 2022; 10:1028691.

PMID: 36561042 PMC: 9763899. DOI: 10.3389/fbioe.2022.1028691.

References
1.
Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S . Amyloid-like properties of bacterial inclusion bodies. J Mol Biol. 2005; 347(5):1025-37. DOI: 10.1016/j.jmb.2005.02.030. View

2.
Ling J, Fan C, Qin H, Wang M, Chen J, Wittung-Stafshede P . Mirror-Image 5S Ribonucleoprotein Complexes. Angew Chem Int Ed Engl. 2019; 59(9):3724-3731. PMC: 7217020. DOI: 10.1002/anie.201914799. View

3.
Ruan A, Ren C, Quan S . Conversion of the molecular chaperone Spy into a novel fusion tag to enhance recombinant protein expression. J Biotechnol. 2019; 307:131-138. DOI: 10.1016/j.jbiotec.2019.11.006. View

4.
Davies P . Ice-binding proteins: a remarkable diversity of structures for stopping and starting ice growth. Trends Biochem Sci. 2014; 39(11):548-55. DOI: 10.1016/j.tibs.2014.09.005. View

5.
Rai J . Peptide and protein mimetics by retro and retroinverso analogs. Chem Biol Drug Des. 2018; 93(5):724-736. DOI: 10.1111/cbdd.13472. View